Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Mesenchymal stromal cell secretome and its key bioactive metabolites induce long-term neuroprotection after traumatic brain injury in mice

ABSTRACT: Mesenchymal stromal cell secretome and its key bioactive metabolites induce long-term neuroprotection after traumatic brain injury in mice

PROVIDER: PRJEB87270 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR14756727.fastq.gz	Fastqsanger.gz
	ERR14756728.fastq.gz	Fastqsanger.gz
	ERR14756729.fastq.gz	Fastqsanger.gz
	ERR14756730.fastq.gz	Fastqsanger.gz
	ERR14756731.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 16

Similar Datasets

p21 produces a bioactive secretome that places stressed cells under immuno-surveillance [dataset 12]

Project description:p21 produces a bioactive secretome that places stressed cells under immuno-surveillance.

2021-10-29 | GSE169329 | GEO

p21 produces a bioactive secretome that places stressed cells under immuno-surveillance [dataset 11]

Project description:p21 produces a bioactive secretome that places stressed cells under immuno-surveillance

2021-10-29 | GSE169327 | GEO

p21 produces a bioactive secretome that places stressed cells under immuno-surveillance [dataset 10]

Project description:p21 produces a bioactive secretome that places stressed cells under immuno-surveillance

2021-10-29 | GSE169326 | GEO

p21 produces a bioactive secretome that places stressed cells under immunosurveillance

Project description:p21 produces a bioactive secretome that places stressed cells under immunosurveillance

| PRJNA481643 | ENA

Uncovering the secretome of mesenchymal stromal cells exposed to healthy, traumatic and 1 degenerative intervertebral discs: A proteomic analysis

Project description:Mesenchymal stromal cells (MSCs) have been introduced as promising cell source for regenerative medicine. Besides their multilineage differentiation capacity, MSCs release a wide spectrum of bioactive factors. This secretome holds immunomodulatory and regenerative capacities. In intervertebral disc (IVD) cells, application of MSC secretome has been shown to decrease the apoptosis rate, induce proliferation and promote production of extracellular matrix (ECM). For clinical translation of secretome-based treatment, characterization of the secretome composition is needed to better understand the induced biological processes and identify potentially effective secretomes. Methods: This study aimed to investigate the proteome released by bone marrow derived MSCs following exposure to a healthy, traumatic, or degenerative human IVD environment by mass spectroscopy and quantitative immunoassay analyses. Exposure of MSCs to the proinflammatory stimulus interleukin 1β (IL-1b) was used as control.

2021-09-09 | PXD021281 | Pride

p21 produces a bioactive secretome that places stressed cells under immunosurveillance [dataset 5]

Project description:p21 produces a bioactive secretome that places stressed cells under immunosurveillance [dataset 5]

| PRJNA486156 | ENA

p21 produces a bioactive secretome that places stressed cells under immunosurveillance [dataset 6]

Project description:p21 produces a bioactive secretome that places stressed cells under immunosurveillance [dataset 6]

| PRJNA486186 | ENA

p21 produces a bioactive secretome that places stressed cells under immunosurveillance [dataset 3]

Project description:p21 produces a bioactive secretome that places stressed cells under immunosurveillance [dataset 3]

| PRJNA483895 | ENA

p21 produces a bioactive secretome that places stressed cells under immunosurveillance [dataset 4]

Project description:p21 produces a bioactive secretome that places stressed cells under immunosurveillance [dataset 4]